Table 2 Endoscopic and Pathological Characteristics of early gastric cardiac cancer
Characters | Total (n = 502) | Absolute indication (n = 271) | Expanded indication (n = 137) | Beyond expanded indication (n = 94) | p value |
|---|---|---|---|---|---|
Direction, number (%) | Â | Â | Â | Â | 0.151 |
 Anterior wall | 13 (2.6) | 9 (3.3) | 2 (1.5) | 2 (2.1) |  |
 Posterior wall | 256 (51.0) | 147 (54.2) | 68 (49.6) | 41 (43.6) |  |
 Lesser curvature | 212 (42.2) | 100 (36.9) | 64 (46.7) | 48 (51.1) |  |
 Greater curvature | 15 (3.0) | 12 (4.4) | 2 (1.5) | 1 (1.1) |  |
 Circumferential | 6 (1.2) | 3 (1.1) | 1 (0.7) | 2 (2.1) |  |
Mean Tumor size (mm), number (%) |  |  |  |  | < 0.001 |
 ≤ 20 | 370 (73.7) | 271 (100) | 52 (38.0) | 47 (50.0) |  |
 20–30 | 87 (17.3) | 0 (0) | 67 (48.9) | 20 (21.3) |  |
 > 30 | 45 (9.0) | 0 (0) | 18 (13.1) | 27 (28.7) |  |
Invasion depth, number (%) |  |  |  |  | < 0.001 |
 LPM | 168 (33.5) | 137 (50.6) | 29 (21.2) | 2 (2.1) |  |
 MM | 189 (37.6) | 134 (49.4) | 52 (38.0) | 3 (3.2) |  |
 SM1 | 74 (14.7) | 0 (0) | 56 (40.9) | 18 (19.1) |  |
 SM2 | 71 (14.1) | 0 (0) | 0 (0) | 71 (75.5) |  |
Endoscopic infiltration (INF) model, number (%) |  |  |  |  | < 0.001 |
 INFa | 333 (66.3) | 198 (73.1) | 88 (64.2) | 47 (50.0) |  |
 INFb | 143 (28.5) | 64 (23.6) | 44 (32.1) | 35 (37.2) |  |
 INFc | 26 (5.2) | 9 (3.3) | 5 (3.6) | 12 (12.8) |  |
Macroscopic type, number (%) |  |  |  |  | < 0.001 |
 0-I | 4 (0.8) | 3 (1.1) | 0 (0) | 1 (1.1) |  |
 0-IIA | 75 (14.9) | 49 (18.1) | 12 (8.8) | 15 (3.0) |  |
 0-IIB | 50 (10.0) | 32 (11.8) | 16 (11.7) | 1 (1.1) |  |
 0-IIC | 227 (45.2) | 112 (41.3) | 74 (54.0) | 41 (43.6) |  |
 0-IIA + IIC | 140 (27.9) | 75 (27.7) | 32 (23.4) | 33 (35.1) |  |
 0-III | 6 (1.2) | 0 (0) | 3 (2.2) | 3 (3.2) |  |
Ulceration, number (%) |  |  |  |  | < 0.001 |
 Presence | 24 (4.8) | 0 (0) | 11 (8.0) | 13 (13.8) |  |
 Absence | 478 (95.2) | 271 (0) | 126 (92.0) | 81 (86.2) |  |
Pathological type, number (%) |  |  |  |  | < 0.001 |
 WD | 279 (55.6) | 179 (66.1) | 78 (56.9) | 22 (23.4) |  |
 MD | 123 (24.5) | 51 (18.8) | 31 (22.6) | 41 (43.6) |  |
 WD + MD | 92 (18.3) | 41 (15.1) | 25 (18.2) | 26 (27.7) |  |
 PD | 8 (1.6) | 0 (0) | 3 (2.2) | 5 (5.3) |  |
Lymphatic and vascular invasion, number (%) |  |  |  |  | < 0.001 |
 Presence | 15 (3.0) | 0 (0) | 1 (0.7) | 14 (14.9) |  |
 Absence | 487 (97.0) | 271 (100) | 136 (99.3) | 80 (85.1) |  |
Esophagus involvement, number (%) |  |  |  |  | < 0.001 |
 Presence | 60 (12.0) | 25 (9.2) | 12 (8.8) | 23 (24.5) |  |
 Absence | 462 (88.0) | 246 (90.8) | 125 (91.2) | 71 (75.5) |  |
Gastritis cystica profunda, number (%) | Â | Â | Â | Â | 0.062 |
 Presence | 122 (24.3) | 55 (20.3) | 40 (29.2) | 27 (28.7) |  |
 Absence | 380 (75.7) | 216 (79.7) | 97 (70.8) | 64 (71.3) |  |
HP infection, number (%) | Â | Â | Â | Â | 0.256 |
 Presence | 285 (56.8) | 149 (55.0) | 87 (63.5) | 54 (57.4) |  |
 Absence | 217 (43.2) | 122 (45.0) | 50 (36.5) | 40 (42.6) |  |
Atrophic gastritis, number (%) | Â | Â | Â | Â | 0.864 |
 Presence | 449 (89.4) | 243 (89.7) | 121 (88.3) | 85 (90.4) |  |
 Absence | 53 (10.6) | 28 (10.3) | 16 (11.7) | 9 (9.6) |  |